RetinaLyze System

What if diabetic eye screenings could also catch early glaucoma? That’s exactly what researchers uncovered in a massive study analyzing over 743,000 retinal images from diabetic patients using RetinaLyze System AI. 6.7% of diabetic eyes showed signs of glaucoma — detected purely from fundus photos. The risk increased with age and years of diabetes. The AI tracked glaucoma progression over time, identifying change in cases with up to 14 exams. This study proves that existing diabetic eye screening networks can double as large-scale glaucoma detection systems — using automated AI analysis, no extra exams needed. 🔗 Published in Journal of Clinical Medicine (JCM) MDPI - full study here: https://lnkd.in/dm4Gja2j New reading material for: Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Medicontur, Medicontur CZ #Ophthalmology #GlaucomaAwareness #ArtificialIntelligence #DiabetesCare #PreventiveHealth #RetinaLyze

From 2D retinal images to > hemoglobin map to > visualization of the Optic Nerve Head (ONH) in 3D! This is what we're able to do with a combination of research and AI. Tissue volume can now be estimated from 2D retinal images instead of OCT. This offers a simpler, faster, and more affordable way to support glaucoma research and testing. Interested in learning more? Head straight to the research paper here: https://lnkd.in/dY_23_af New reading material for: Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Medicontur, Medicontur CZ #AIinHealthcare #Ophthalmology #MedicalImaging #Telemedicine #RetinaLyze

A 79-year-old patient recently visited an optometrist using RetinaLyze System for a routine eye check. The optometrist noted abnormal findings on both fundus images and OCT scans. Visual acuity: 0.2 in both eyes. To ensure a fast and qualified assessment, they submitted the case via our integrated telemedical workflow for evaluation by an ophthalmologist. 🔍 The response came swiftly: "The patient has wet AMD with active CNV (Choroidal neovascularization) in the left eye, retinal hemorrhages, intraretinal edema, and serous detachment, and must be referred to an ophthalmologist immediately." Thanks to the seamless integration with the national Danish referral system (DNHF / Henvisningshotellet), a digital referral was sent on the spot, and the patient was advised to go directly to the ophthalmic emergency department. 🩺 This is a perfect example of how collaboration between optometrists and ophthalmologists can lead to faster decisions, earlier treatment, and better outcomes for patients. Huge thanks to the optometrist and the RetinaLyze ophthalmology team for acting swiftly and decisively. New reading material for: Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Bloss Group, Medicontur, Medicontur CZ #eyecare #retinalyze #telemedicine #optometry #ophthalmology #AMD #digitalhealth #AIinHealthcare

New integration: Phelcom Eyer II × RetinaLyze AI We’re excited to announce a powerful new integration: The Phelcom Eyer II handheld retinal camera now works seamlessly with RetinaLyze AI. This means clinics, optometrists, and outreach programs can now: ✅ Capture high-quality retinal images with the portable Eyer II ✅ Instantly analyze for signs of diabetic retinopathy, AMD, and glaucoma using RetinaLyze AI ✅ Make screening faster, more accessible, and more scalable – without compromising on clinical quality This integration is another step toward our shared mission with Phelcom Technologies led by CEO, Jose Stuchi, PhD, MBA – making eye screening accessible anywhere. If you're already using the Eyer II or thinking about expanding your screening capabilities, this is the upgrade you've been waiting for! 🔗 Want a demo or more details? Let’s talk! https://lnkd.in/dqZ8Xhgm New reading material for: Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Medicontur, Medicontur CZ #eyecare #retina #teleophthalmology #AIinHealthcare #RetinaLyze #PhelcomEyer #ophthalmology

Can we detect #glaucoma before the damage is done? A new study published in BMJ Open Ophthalmology (Ophthalmology at BMJ) led by Eduardo Jerez-Olivera and team explores just that — and the results are promising. Using the Laguna/RetinaLyze AI-based application, researchers demonstrated that the morphology of the optic nerve — both in healthy eyes and those affected by glaucoma — can be accurately estimated from blood perfusion, specifically the distribution of haemoglobin (Hb). Key takeaways: - There’s a strong correlation (R=0.953) between Hb density and actual optic nerve tissue thickness. - The rim volume (RV) and cup volume (CV) — critical glaucoma markers — can be estimated with high accuracy from standard color fundus photos. This method was tested not only in clinical settings but across over 1.1 million images from real-world glaucoma screenings (provided by RetinaLyze System). Why this matters: Traditional OCT scans are precise but expensive, time-consuming, and not always accessible — especially for large-scale screening. This study shows how AI and non-stereoscopic photography can offer faster, more scalable, and cost-effective diagnostics — potentially catching glaucoma earlier. 👏 Congrats to the authors, including: Dr. Manuel González de la Rosa (INSOFT SL & Universidad de La Laguna) Marta and Daniel González Hernández, and Eduardo Jerez-Olivera. This could be a step toward making AI-assisted glaucoma detection a global standard - especially where access to advanced diagnostic tools (like #OCT) is limited. Read the full open-access study here: https://lnkd.in/dY_23_af New reading material for: Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Medicontur, Medicontur CZ #AIinHealthcare #Ophthalmology #MedicalImaging #Telemedicine #RetinaLyze

Another second shaved off — and every second counts! We're proud to share that a RetinaLyze eye screening is now performed every 35 seconds by our incredible customers around the world. From Danish optometrists to Mexican hospitals — and everywhere in between — AI-aided eye screening is becoming the standard. This isn't just a number. It's early detection. It's better outcomes. It's smarter healthcare. It's your trust in action — and we’re just getting started. To everyone helping us on this journey, thank you so much for fighting preventable blindness with us! 👉 Curious how RetinaLyze can fit into your workflow? Let’s talk: https://lnkd.in/dqZ8Xhgm THANK YOU! 👏 Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Medicontur, Medicontur CZ Canon Medical Systems Europe, Essilor, NIDEK Global, OPTOPOL Technology, Rodenstock, Topcon Healthcare Europe, TOMEY GmbH, ZEISS Medical Technology #AIinHealthcare #RetinaLyze #EyeHealth #AIEyeScreening #HealthcareInnovation #Ophthalmology #Optometry #MedicalAI

New research highlights the potential of automated optic nerve head hemoglobin (ONH Hb) measurements in detecting glaucoma progression! A study led by Prof. Dr. Tiago Prata and colleagues, published in Journal of Glaucoma (World Glaucoma Association), assessed how the Globin Individual Pointer (GIP) index, generated by the RetinaLyze Glaucoma software, can spot structural progression in glaucoma using just 2 color fundus images. 87 eyes were analyzed — 35 with progression and 52 without. Results showed that GIP values dropped significantly in progressing eyes, especially when neuroretinal rim (NR) changes were present. KEY TAKEAWAYS: GIP index detected 69% of progressors overall Best performance when NR changes were present (AUROC 0.76) Only 2 color retinographies needed — fast, low-cost, and practical A promising first-stage screening tool for glaucoma progression May be especially useful in resource-limited settings or for retrospective analysis WHY DOES THIS MATTER? Detecting glaucoma progression early is key to preventing vision loss. This method could increase accessibility to monitoring, especially where OCT isn’t available or follow-up is limited. Read the full article here: https://lnkd.in/dnGswHke Thanks to the research team: Janaína Rocha Lopes, Thaíssa Goytacaz, Maria Betânia Lemos, Augusto Paranhos Jr, Sérgio Oliveira Pires Teixeira, Fabio Kanadani, Carolina Pelegrini Barbosa Gracitelli, and Tiago Santos Prata. 👏 Some new reading material for: Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, Medicontur, Medicontur CZ #Glaucoma #AIinHealthcare #RetinaLyze #EyeCare #Ophthalmology #Innovation #AIinOphthalmology #VisionHealth

A webinar exclusively for RetinaLyze D-A-CH customers! Following the enthusiastic feedback on our first Impulse Webinar last year, we’re excited to invite RetinaLyze System® subscribers to a new edition with even more insights and practical tips! 📌 Impulse Webinar (in German) Topic: Recognizing, leveraging, and communicating the value of eye screening services—while keeping legal considerations in mind. 📅 Dates: • April 1, 2025 | 18:30–20:15 • April 3, 2025 | 09:00–09:45 Where? Online 👩🏫 Speaker: Regina Otto, RetinaLyze® Ambassador & Trainer 🎙️ Moderation: Ingo Rütten, Partnerauge What to expect: ✔️ How eye screening benefits your business and your customers ✔️ Legal aspects to consider in service execution and communication ✔️ Best practices in interpreting and discussing screening results Check your email if you are a RetinaLyze DACH customer! See you there! 😁 Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil, Bloxx Digital Innovation, #RetinaLyze #EyeScreening #Webinar #Optometry #EyeHealth #LegalCompliance #AI

New study sheds light on AI-assisted diabetic eye screening using RetinaLyze System in general practices! A recently published interview study in Frontiers in Medicine explores how general practice staff experienced integrating AI-assisted diabetic retinopathy screening (DRS) into their daily routines. 12 clinics in the North Denmark Region tested AI-assisted screening 300 patients with type 2 diabetes. Afterwards, 21 staff members were interviewed to gain insights into their experiences. Key findings: - The screening was perceived as fast and easy, but required workflow adjustments - Successful implementation depends on clinical setup, funding, and staff training - Staff showed trust in the AI tool – accuracy and reliability are essential for adoption - The screening has the potential to reduce unnecessary referrals, improve access to eye screening, and relieve ophthalmology departments Why does this matter? Integrating AI-assisted DRS into general practice could mean that only patients with early signs of diabetic eye disease are referred to specialists, ensuring more efficient use of ophthalmologists’ time. It could also help reach patients who aren’t currently being screened, enabling earlier detection and prevention of vision loss. Read the full article here: https://lnkd.in/dVfafuvu Thanks to the authors: Malene Krogh, Jette Kolding Kristensen, Morten Sig Ager Jensen, Martin Bach Jensen, Marie Germund Nielsen, Henrik Vorum, Malene Hentze Hansen 📢 More to come – we look forward to sharing results soon on patients’ perspectives and the validation of AI-assisted screening! Thanks to RODENSTOCK Instruments for providing the retinal camera! Teddy Birch Petersen, Morten Kirk Guldager, Thomas Degn Nielsen, Ganesh Ram, Michael Anthonsen, Barbara Anthonsen, Zaneta Geltz, René Asserfelt CEO Retinalyze España SL, Chris Flynn, Peter Jørgensen, Mario Simoniello, Nestor Sequeiros, Alessandra Sequeiros, Rene Pessoto, Rudolf Zelenka, Miroslava Chládková, Matej Leško, Marius Nastasescu, Olga Blendea, Daniela Losada Bloss, Enrique Losada, Diego Losada Bloss, Alba Baños Oliveras, Jose Manuel Tamarit, Mabel Sofía Rubial Arellano RetinaLyze D-A-CH, RetinaLyze España, RetinaLyze UK, RetinaLyze Brasil #Diabetes #AI #HealthTech #GeneralPractice #RetinaLyze #PrimaryCare #DigitalHealth #Ophthalmology #DiabeticRetinopathy #Innovation #AIMedicine #Screening #EyeHealth

New study examining #optic nerves and #glaucoma of 481 eyes found a strong correlation (R=0.953) between optic nerve perfusion (Hb density) & Bruch’s membrane thickness using #OCT & Laguna ONhE. Could perfusion-based metrics aid in earlier diagnosis of glaucoma? https://bit.ly/4iUbS2j #Vision #Optometry #Ophthalmology #AI #NeuroOphthalmology